UA94464C2 - Выделенное антитело к dll4 и его применение - Google Patents
Выделенное антитело к dll4 и его применениеInfo
- Publication number
- UA94464C2 UA94464C2 UAA200900120A UAA200900120A UA94464C2 UA 94464 C2 UA94464 C2 UA 94464C2 UA A200900120 A UAA200900120 A UA A200900120A UA A200900120 A UAA200900120 A UA A200900120A UA 94464 C2 UA94464 C2 UA 94464C2
- Authority
- UA
- Ukraine
- Prior art keywords
- isolated anti
- methods
- same
- dll4 antibody
- antibody
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102100033553 Delta-like protein 4 Human genes 0.000 abstract 1
- 101000872077 Homo sapiens Delta-like protein 4 Proteins 0.000 abstract 1
- 239000004037 angiogenesis inhibitor Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Изобретение относится к выделенному антителу к дельта-подобному лиганду человека (DLL4), полинуклеотиду, который его кодирует, вектору, клетке-хозяину, способу получения данного антитела и композиции, которая его содержит. Изобретение также относится к способу диагностики расстройства, ассоциированного с экспрессией DLL4, способу лечения опухоли, рака или клеточной пролиферации и способу повышения эффективности антиангиогенного средства у индивидуума.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81135706P | 2006-06-06 | 2006-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA94464C2 true UA94464C2 (ru) | 2011-05-10 |
Family
ID=40891998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200900120A UA94464C2 (ru) | 2006-06-06 | 2007-06-06 | Выделенное антитело к dll4 и его применение |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101489576A (ru) |
| UA (1) | UA94464C2 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130078247A1 (en) * | 2011-04-01 | 2013-03-28 | Boehringer Ingelheim International Gmbh | Bispecific binding molecules binding to dii4 and ang2 |
-
2007
- 2007-06-06 UA UAA200900120A patent/UA94464C2/ru unknown
- 2007-06-06 CN CNA2007800260280A patent/CN101489576A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN101489576A (zh) | 2009-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA95068C2 (ru) | Антиген-связующая молекула, которая связывает egfr, вектор, который ее кодирует, и их применение | |
| MX2009009787A (es) | Mutaciones de k-ras y terapia con anticuerpos anti-egfr. | |
| UA102891C2 (ru) | Полные человеческие антитела, специфические к cadm1 | |
| TN2011000524A1 (en) | Antibodies specific to cadherin -17 | |
| PH12012501720A1 (en) | Therapeutic dll4 binding proteins | |
| MX2022009759A (es) | El uso de 1-(4-ciano-3-trifluorometil-fenil)-3-[7-(4-ciano-3-trifl uorometil-fenil)-6-tioxo-5-p-tolilo-5,7-diazaespiro[3.4]oct-8-ili deno]-tiourea. | |
| MX2009009779A (es) | Mutaciones de k-ras y b-raf y terapia con anticuerpos anti-egfr. | |
| PH12013500353A1 (en) | Novel antigen binding proteins | |
| BRPI0611670A2 (pt) | método para o tratamento ou prevenção de câncer em um indivíduo | |
| BRPI0918555A2 (pt) | anticorpo, composição, molécula de ácido nucleico, método de tratamento de um tumor maligno em um animal, e, uso da composição. | |
| UA94707C2 (en) | Antigen-binding molecule capable of binding to plgf | |
| WO2009120899A3 (en) | G coupled protein receptors associated with myelogenous haematological proliferative disorders and uses thereof | |
| NZ606195A (en) | Methods and compositions for liver cancer therapy | |
| WO2009150470A3 (en) | Suppression of cancers | |
| WO2008011519A3 (en) | Amigo-2 inhibitors for treating, diagnosing or detecting cancer | |
| WO2009074968A3 (en) | Method for predicting the efficacy of cancer therapy | |
| NZ703411A (en) | Use of markers in the diagnosis and treatment of prostate cancer | |
| MA32288B1 (fr) | Nouveaux anticorps utiles pour le traitement du cancer | |
| TNSN08401A1 (en) | Methods of treating diagnosing or detecting cancer | |
| WO2019027987A3 (en) | COMPOSITIONS AND METHODS FOR TARGETING MASAS TO TREAT CANCERS WITH SPLICE COMPLEX MUTATIONS | |
| WO2010099139A3 (en) | Combination of an either an anti-igf-ir- antibody or an igf binding protein and a small molecule igf-ir kinease inhibitor | |
| UA94464C2 (ru) | Выделенное антитело к dll4 и его применение | |
| WO2007033167A3 (en) | Compositions and methods for detecting and treating cancer | |
| WO2010080248A3 (en) | Peptides that bind eukaryotic translation initiation factor 4e | |
| WO2006086772A3 (en) | DIAGNOSING AND TREATING CANCER USING β-CATENIN SPLICE VARIANTS |